- Home
- ZKIN vs CASI Comparison
ZKIN vs CASI Comparison
Compare ZKIN & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZKIN | CASI |
|---|---|---|
| Founded | 2015 | 1991 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5M | 24.9M |
| IPO Year | 2017 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ZKIN | CASI |
|---|---|---|
| Price | $1.70 | $0.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 15.1K | ★ 34.9K |
| Earning Date | 09-29-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $95,309,093.00 | $26,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $0.82 | $0.75 |
| 52 Week High | $5.95 | $3.47 |
Technical Indicators
Market Signals| Indicator | ZKIN | CASI |
|---|---|---|
| Relative Strength Index (RSI) | 35.83 | 28.05 |
| Support Level | $1.20 | $0.83 |
| Resistance Level | $1.94 | $0.95 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 44.53 | 0.00 |
Price Performance
Historical ComparisonAbout ZKIN ZK International Group Co. Ltd
ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.